UPI MDR row: CA flags pressure on low-margin businesses; pharma company director estimates ₹1.2 crore annual hit

A proposed 0.4% UPI MDR on larger merchant payments is drawing concern from businesses operating on thin margins. CA Kanan Bahl and pharma executive Rahul Mamman have highlighted the potential hit to business profitability.